CG
HZNP

Cutler Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Cutler Group’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,500
Closed -$1K – 4601
2023
Q3 		$1K Sell
4,500
-36,900
-89% -$3.96M ﹤0.01% 3711
2023
Q2 		$34K Buy
41,400
+38,800
+1,492% +$4.09M ﹤0.01% 1541
2023
Q1 		$4K Sell
2,600
-25,400
-91% -$2.81M ﹤0.01% 2892
2022
Q4 		$3K Buy
+28,000
New +$2.33M ﹤0.01% 3598
2022
Q2 		– Sell
-7,200
Closed -$16K – 6068
2022
Q1 		$16K Sell
7,200
-2,400
-25% -$234K ﹤0.01% 3257
2021
Q4 		$19K Buy
9,600
+3,800
+66% +$415K ﹤0.01% 3193
2021
Q3 		$28K Buy
5,800
+2,800
+93% +$291K ﹤0.01% 3055
2021
Q2 		$33K Sell
3,000
-16,500
-85% -$1.52M ﹤0.01% 2862
2021
Q1 		$66K Buy
19,500
+3,100
+19% +$262K ﹤0.01% 2119
2020
Q4 		$19K Sell
16,400
-13,600
-45% -$1.01M ﹤0.01% 2739
2020
Q3 		$59K Buy
+30,000
New +$2.06M ﹤0.01% 1697
2018
Q1 		– Sell
-8,300
Closed -$4K – 5702
2017
Q4 		$4K Sell
8,300
-7,100
-46% -$99.7K ﹤0.01% 3888
2017
Q3 		$30K Sell
15,400
-6,000
-28% -$76.3K ﹤0.01% 2757
2017
Q2 		$49K Sell
21,400
-123,200
-85% -$1.53M ﹤0.01% 2526
2017
Q1 		$99K Sell
144,600
-105,000
-42% -$1.7M ﹤0.01% 1749
2016
Q4 		$254K Buy
249,600
+145,900
+141% +$2.65M 0.01% 1123
2016
Q3 		$213K Buy
103,700
+60,000
+137% +$1.17M 0.01% 1155
2016
Q2 		$113K Buy
43,700
+19,600
+81% +$317K 0.01% 1587
2016
Q1 		$85K Sell
24,100
-35,700
-60% -$625K 0.01% 1781
2015
Q4 		$75K Buy
+59,800
New +$1.16M ﹤0.01% 2050

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Cutler Group's HZNP Position: Q4 2023 in Review

Cutler Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 6,450 shares — an estimated $746K sold.

Cutler Group first reported a position in HZNP in Q4 2015 and held it in 27 quarters. The position peaked at $3.19M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Cutler Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 6,450 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $746K.
  • Cutler Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 27 quarters.
  • Cutler Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.19M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.